Pulmonx Completes Enrollment in U.S. Pivotal Trial of Zephyr®Endobronchial Valve

  • Posted by Jenna Widdison
  • On October 5, 2016
Redwood City, Calif. – October 5, 2016 – Pulmonx, a leader in interventional pulmonology, today announced completion of enrollment in its pivotal IDE study – the LIBERATE Trial – a randomized, controlled, multi-center study of the Zephyr® Endobronchial Valve (EBV) in patients with severe emphysema,...
Read More